(hydroxyzine pamoate)
Vistaril Capsules (hydroxyzine pamoate equivalent to hydroxyzine hydrochloride)
25 mg: | 100's (NDC 0069-5410-66), two-tone green capsules | |
50 mg: | 100's (NDC 0069-5420-66), green and white capsules |
Store Vistaril® Capsules below 30°C (86°F). Dispense in tight, light-resistant containers (USP).
Vistaril Oral Suspension (hydroxyzine pamoate equivalent to 25 mg hydroxyzine hydrochloride per teaspoonful-5 mL): 1 pint (473 mL) bottles (NDC 0069-5440-93) and 4 ounce (120 mL) bottles (NDC 0069-5440-97) in packages of 4.
Store Vistaril® Oral Suspension at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Shake vigorously until product is completely resuspended.
This product's label may have been updated. For full prescribing information, please visit www.pfizer.com.
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.